Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Gains from Investment Securities: 2016-2023

Historic Gains from Investment Securities for SRx Health Solutions (SRXH) over the last 8 years, with FY2023 value amounting to $54.0.

  • SRx Health Solutions' Gains from Investment Securities fell 2124.65% to $278000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $985000.0, marking a year-over-year decrease of 4617.49%. This contributed to the annual value of $54.0 for FY2023, which is 2285.71% down from last year.
  • As of FY2023, SRx Health Solutions' Gains from Investment Securities stood at $54.0, which was down 2285.71% from $70.0 recorded in FY2022.
  • SRx Health Solutions' 5-year Gains from Investment Securities high stood at $22.7 million for FY2020, and its period low was -$23.5 million during FY2021.
  • For the 5-year period, SRx Health Solutions' Gains from Investment Securities averaged around -$148775.2, with its median value being $70.0 (2022).
  • In the last 5 years, SRx Health Solutions' Gains from Investment Securities soared by 5521219.51% in 2020 and then tumbled by 20346.15% in 2021.
  • Annual analysis of 5 years shows SRx Health Solutions' Gains from Investment Securities stood at $41000.0 in 2019, then surged by 55212.2% to $22.7 million in 2020, then plummeted by 203.46% to -$23.5 million in 2021, then soared by 100.0% to $70.0 in 2022, then dropped by 22.86% to $54.0 in 2023.
  • Its Gains from Investment Securities was $54.0 in FY2023, compared to $70.0 in FY2022 and -$23.5 million in FY2021.